Chelsea And Westminster Nhs Foundation Trust

This study followed 200 transgender and non-binary people living with HIV across Europe for 18 months. Researchers collected data from routine blood tests to see how well HIV treatment was working. The goal was to learn more about this group's health needs and help shape future t…

This study looked at how dolutegravir, an HIV medication, changes how the body handles sugar, fats, and hormones in 16 healthy volunteers without HIV. The goal was to understand why some HIV patients gain weight while taking this drug. Participants took the drug for a short time …